DOI: 10.12890/2024_004812
From diagnosis to treatment: a successful case of haemophagocytic lymphohistiocytosis of presumed bacterial aetiology in an adult
Authors
catarinapsantos3@gmail.com
Keywords
Haemophagocytic lymphohistiocytosis, haemophagocytic syndrome, haemophagocytosis, hyperferritinaemiaAbstract
Haemophagocytic lymphohistiocytosis (HLH) affects patients across all age groups and can be classified as either primary HLH (P-HLH) or secondary HLH (S-HLH). The latter is associated with clinical conditions that disrupt normal immunological responses, such as infections, neoplasms or autoimmune diseases. Although HLH can occur sporadically in healthy individuals, it is more frequently observed in patients with haematological malignancies and autoimmune disorders.
The diagnostic process for HLH is often challenging due to its non-specific signs and the absence of pathognomonic findings. The primary objective in treating S-HLH is to eliminate the underlying trigger and control immunological hyperactivation, making the identification and treatment of triggers critically important. Prompt diagnosis and treatment are essential, as the mortality rate remains high. In this context, we present the case of a young woman diagnosed with idiopathic S-HLH, likely triggered by a bacterial infection. The diagnosis was achieved due to a high index of clinical suspicion for S-HLH. The patient exhibited an excellent response to antimicrobial therapy, resulting in the complete resolution of haemophagocytosis. The authors deem it important to present this case to enhance awareness of S-HLH diagnosis, as well as the investigation and management of potential triggers.
References
- Skinner J, Yankey B, Shelton BK. Hemophagocytic lymphohistiocytosis. AACN Adv Crit Care 2019;30:151–164.
- Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 2020;34:101515.
- Al-Samkari H, Berliner N. (2018). Hemophagocytic lymphohistiocytosis. Annu Rev Pathol 2018;13:27–49.
- Ponnatt TS, Lilley CM, Mirza KM. Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med 2022;146:507–519.
- Campo M, Berliner N. Hemophagocytic lymphohistiocytosis in adults. Hematol Oncol Clin North Am 2015;29:915–925.
- Pai TS, Stancampiano FF, Rivera C. Hemophagocytic lymphohistiocytosis for the internist and other primary care providers. J Prim Care Community Health 2021;12:21501327211053756.
- Machowicz R, Basak, G. How can an internal medicine specialist save a patient with hemophagocytic lymphohistiocytosis (HLH)? Pol Arch Intern. Med 2020;130:431–437.
- Naymagon, L. Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms. Pathol Res Pract 2021;218;153321.
- Kim YR, Kim DY. Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults. Blood res 2021;56:S17–S25.
- Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2015;2015:177–182.
